BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3524784)

  • 21. Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease.
    Cox F; Trincher R; Rissing JP; Patton M; McCracken GH; Granoff DM
    JAMA; 1981 Mar; 245(10):1043-5. PubMed ID: 6970272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute epiglottitis caused by Haemophilus influenzae type b in children: presentation of 21 cases].
    del Carmen Otero M; Sanchís N; Modesto V; Pérez-Tamarit D; Asensi F; Santos M
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):462-7. PubMed ID: 9527370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low rate of nasopharyngeal carriage and high rate of ampicillin resistance for Haemophilus influenzae among healthy children younger than 5 years old in northern Taiwan.
    Wang SR; Lo WT; Chou CY; Chen YY; Tsai SY; Chu ML; Wang CC
    J Microbiol Immunol Infect; 2008 Feb; 41(1):32-40. PubMed ID: 18327424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carriage and antibiotic susceptibility of Haemophilus influenzae type b and non b in Danish day-care attendees.
    Kristensen K
    APMIS; 1990 Jan; 98(1):50-2. PubMed ID: 2302341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of immunization on Haemophilus influenzae type b disease.
    Madore DV
    Infect Agents Dis; 1996 Jan; 5(1):8-20. PubMed ID: 8789595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
    Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
    Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and phenotypic characterization of Haemophilus influenzae type b isolated from children with meningitis and their family members in Vietnam.
    Phan LT; Ngo TT; Dang DA; Vu TT; Le NM; Tran QC; Matsuoka M; Kamachi K; Yamazaki T; Arakawa Y; Sasaki T
    Jpn J Infect Dis; 2006 Apr; 59(2):111-6. PubMed ID: 16632911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin.
    Granoff DM; Gilsdorf J; Gessert C; Basden M
    Pediatrics; 1979 Mar; 63(3):397-401. PubMed ID: 312483
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute epiglottitis: therapeutic consequences of change in the resistance of Haemophilus influenzae serotype B].
    Paul T; Galaske RG; Kallfelz HC
    Monatsschr Kinderheilkd; 1988 Apr; 136(4):190-2. PubMed ID: 3290661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease.
    Murphy TV; Clements JF; Breedlove JA; Hansen EJ; Seibert GB
    N Engl J Med; 1987 Jan; 316(1):5-10. PubMed ID: 3491319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease.
    Wood N; Menzies R; McIntyre P
    Intern Med J; 2005 Sep; 35(9):530-5. PubMed ID: 16105154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland.
    Takala AK; Peltola H; Eskola J
    Laryngoscope; 1994 Jun; 104(6 Pt 1):731-5. PubMed ID: 8196448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
    McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
    Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection of Haemophilus influenzae type b in Bangladeshi children with pneumonia and meningitis by PCR and analysis of antimicrobial resistance.
    Shoma S; Rahman M; Yasmin M
    J Health Popul Nutr; 2001 Dec; 19(4):268-74. PubMed ID: 11855348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae.
    McDougal LK; Thornsberry C
    J Antimicrob Chemother; 1982 May; 9(5):369-78. PubMed ID: 6980217
    [No Abstract]   [Full Text] [Related]  

  • 36. [Type B Haemophilus influenzae infections. Experience at the Pediatric Hospital of Luxembourg].
    De Jonghe M; Glaesener G
    Bull Soc Sci Med Grand Duche Luxemb; 1995; 132(2):17-20. PubMed ID: 7497542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Ajello G
    JAMA; 1984 May; 251(18):2381-6. PubMed ID: 6368889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
    Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
    Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Invasive Haemophilus influenzae type B infections in infancy (1981-1990)].
    de Juan Martín F; Campos Calleja C; Bustillo Alonso M; Baldovín Ballesteros I; Bello Andrés E; Elviro Mayoral L
    An Esp Pediatr; 1993 Aug; 39(2):111-5. PubMed ID: 8239205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The decline of Haemophilus influenzae type b disease in Australia.
    Herceg A
    Commun Dis Intell; 1997 Jun; 21(13):173-6. PubMed ID: 9222159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.